Ondine Biomedical Inc (OBI) NPV

- Add to watchlist
- Create an alert
- This stock can be held in a




15.75p
16.03p
18.25p
£69.97 million
16.50p
15.00p
5.63p
n/a
0.00p (0.00%) Previous:
0.00p
2,287,459
n/a
20,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 1.20 | 0.64 |
Profit before tax ($m) | (14.41) | (19.37) |
Adjusted EPS (¢): | (7.00) | (10.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Ondine to pilot Steriwave at Mexico City hospital
13 August 2025 14:50
-
Ondine completes landmark Steriwave study
21 July 2025 12:30
-
Ondine Biomedical upbeat on new Steriwave test data
9 June 2025 15:59
-
Result of Fundraise & TVR
28 August 2025 07:00
-
Proposed c.£11m Fundraise
27 August 2025 16:52
-
First Mexican Hospital Steriwave Deployment
13 August 2025 10:52
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.